NHT
New Hampshire Trust’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Sell |
9,957
-168
| -2% | -$7.78K | 0.1% | 118 |
|
|
2025
Q1 | $618K | Buy |
10,125
+30
| +0.3% | +$1.83K | 0.14% | 91 |
|
|
2024
Q4 | $571K | Sell |
10,095
-188
| -2% | -$10.6K | 0.12% | 104 |
|
|
2024
Q3 | $532K | Hold |
10,283
| – | – | 0.11% | 113 |
|
|
2024
Q2 | $427K | Sell |
10,283
-1,210
| -11% | -$50.3K | 0.1% | 125 |
|
|
2024
Q1 | $623K | Sell |
11,493
-305
| -3% | -$16.5K | 0.15% | 98 |
|
|
2023
Q4 | $605K | Sell |
11,798
-195
| -2% | -$10K | 0.15% | 103 |
|
|
2023
Q3 | $696K | Sell |
11,993
-77
| -0.6% | -$4.47K | 0.19% | 88 |
|
|
2023
Q2 | $772K | Sell |
12,070
-639
| -5% | -$40.9K | 0.2% | 89 |
|
|
2023
Q1 | $881K | Sell |
12,709
-283
| -2% | -$19.6K | 0.24% | 83 |
|
|
2022
Q4 | $935K | Buy |
+12,992
| New | +$935K | 0.25% | 86 |
|